Evidence map›Paper›PMID 33994733›Full record

ArticleIndian journal of surgical oncology2021

mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study.

Puneet Kumar, Arun Sebastian, Khushi Verma, Ruhi Dixit, Soni Kumari, Juhi Singh, Satyendra Kumar Tiwary, Gopeshwar Narayan

Open access · greenAbstract read
In one paragraph

Article in Indian journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. F-box and leucine-rich repeat 6 promotes gastric cancer progressionWorld journal of gastrointestinal oncology · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Puneet KumarDepartment of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 India.
Arun SebastianDepartment of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 India.
Khushi VermaDepartment of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 India.
Ruhi DixitDepartment of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 India.
Soni KumariDepartment of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 India.
Juhi SinghDepartment of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 India.
Satyendra Kumar TiwaryDepartment of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005 India.
Gopeshwar NarayanDepartment of Molecular and Human Genetics, Institute of Science, Banaras Hindu University, Varanasi, 221005 India.
Banaras Hindu University · INInstitute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is a serious fatal cancer on a global scale because of its presentation at advanced stage. The expressions of vascular endothelial growth factor (VEGF), E-cadherin, and matrix metalloproteinases (MMPs) in other cancers have been reported. However, its expression and underlying mechanisms are little known in gastric cancer in Indian context. In this study, we detected mRNA expression of VEGF, E-cadherin, and MMPs (MMP-1, MMP-2, and MMP-9) in 73 gastric cancer tissues and 27 normal controls by reverse-transcriptase polymerase chain reaction (RT-PCR). Receiver operator characteristics analysis was done for determining the diagnostic utility of VEGF, MMPs and E-cadherin with respect to the sensitivity and specificity. The association of VEGF, MMPs, and E-cadherin expression with the clinicopathological characteristics and the prognosis was subsequently analyzed. The mRNA expression results showed that E-cadherin was significantly downregulated in 47.9% of GC in comparison to control. There was no change in VEGF expression observed in 90.4% GC cases. MMP-1, MMP-2, and MMP-9 were overexpressed in 13.7%, 28.8%, and 11% of GC, respectively, with significant change in MMP-2 (

Indexed as

Diagnostic utilityE-cadherinGastric cancerMMPsVEGF

Identifiers

PMID33994733
PMCPMC8119595
OpenAlexW3027990105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.